A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders.
OBJECTIVE
To assess microbial contamination of 20% autologous serum (AS) eye drops used in a hospital inpatient setting.


METHODS
14 patients received autologous serum drops from 4 to 14 days with a cumulative total of 67 days. For each day the first and last drop (total 134 samples) was cultured on broth and blood agar.


RESULTS
Four patients (9 samples) grew Staphylococcus epidermidis only. One patient (1 sample) showed Staphylococcus epidermidis and a scanty growth of viridans streptococci in the same sample, and on different days the same patient grew Staphylococcus aureus in one sample and Staphylococcus epidermidis in another sample. One patient (1 sample) grew micrococcus. There was no clinical or microbial evidence of infection in any of these six patients.


CONCLUSIONS
This study shows that autologous serum drops can be safely used in an inpatient setting, under a strict protocol of preparation and storage, without significant risk of bacterial contamination and consequent infection.
Lagnado
R
R
Division of Ophthalmology and Visual Sciences, Eye Ear Nose Throat Centre, University of Nottingham, University Hospital, Queens Medical Centre, Nottingham NG7 2UH, UK.
King
A J
AJ
Donald
F
F
Dua
H S
HS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000517:prevention & control*; D002985:Clinical Protocols; D003316:Corneal Diseases / Q000628:therapy; D015352:Dry Eye Syndromes / Q000628:therapy; D005128:Eye Diseases / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D044967:Serum
D009883:Ophthalmic Solutions